ResearcherNational Cheng Kung UniversityActive in the last 2 years
Chang-Jung Chen
Matched on ORCID iD 0009-0008-4283-0842; OpenAlex author ID A5070931222. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2024: 1 paper · 2025: none · 2026: 1 paper
Papers 2
- Heparanase blockade sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy and unleashes antitumor immunity. Co-author DOI 10.1016/j.biopha.2026.119442↗
- Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment. Co-author DOI 10.1158/1535-7163.mct-23-0767↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hao‐Chen Wang · 2 shared papers, 2024–2026 · strength 0.57
- Paper Heparanase blockade sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy and unleashes antitumor immunity. DOI 10.1016/j.biopha.2026.119442↗
- Paper Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion fo… DOI 10.1158/1535-7163.mct-23-0767↗
- Yan‐Shen Shan · 2 shared papers, 2024–2026 · strength 0.57
- Paper Heparanase blockade sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy and unleashes antitumor immunity. DOI 10.1016/j.biopha.2026.119442↗
- Paper Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion fo… DOI 10.1158/1535-7163.mct-23-0767↗
- Ya‐Chin Hou · 1 shared paper, 2024 · strength 0.26
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.